What's behind Reckitt Benckiser's latest 1.6% stock pullback?

What's behind Reckitt Benckiser's latest 1.6% stock pullback?
Reckitt benckiser slides 1.63% today

Reckitt Benckiser Group plc (RKT) fell 1.63% after opening with a downside gap, even as the company's second-quarter 2026 results highlighted accelerated sales growth and a new £500 million buyback program. The decline is constrained by the stock's strong position above key short- and medium-term moving averages, signaling underlying technical support.

RKT price prediction
24H -0.37%
GBX 5,681
48H -0.32%
GBX 5,684
7D 0.37%
GBX 5,723
1M 7.7%
GBX 6,141
3M -5.81%
GBX 5,370.88
6M -18.37%
GBX 4,654.41
12M -22.61%
GBX 4,412.89
Current price: GBX 5,702 34.00 0.60%
Closed 11/13
Daily range 5652.00 Arrow from to Icon 5716.00
Weekly range 5574.00 Arrow from to Icon 5728.00
Loading...

Highlights

  • Reckitt Benckiser's Q2 2026 like-for-like net revenue grew 4.2%, with core segments up 4.2%–4.7%, aided by a £500 million share buyback launch.
  • Interim dividend increased 5% to 88.6 pence per share, while net profit dropped to £652 million and full-year guidance remained unchanged.
  • Despite strong bullish momentum and overbought signals, short-term profit-taking holds price near GBX5,310–GBX5,392, with a projected trading range of GBX4,990–GBX5,634 over five days.

Investor caution grows as sales advance contrasts with profit drop

Reckitt Benckiser reported a significant acceleration in second-quarter 2026 sales, with like-for-like net revenue rising by 4.2% and core segment growth of 4.2% to 4.7%. The company launched a £500 million share buyback program to be executed over the next year and increased its interim dividend by 5% to 88.6 pence per share. First-half net profit decreased to £652 million from £958 million the previous year, and full-year guidance for both revenue growth and adjusted operating margin was maintained. The divestment of the Russia Hygiene business was completed, accompanied by continued capital returns, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, emphasizes that Reckitt Benckiser's latest results brought weaker net profit and ongoing selling pressure, despite a headline buyback. He points to overbought technical signals and the stock's failure to reclaim the 200-day moving average as key warning signs. Kharitonov is cautious about short-term upside, noting that profit-taking and volatility threaten any sustained rally. He sees limited near-term catalysts, particularly after the Russia Hygiene business divestment and margin stagnation. He warns that a break below GBX5,310 would expose Reckitt to sharper losses. "Current sentiment is stretched and the risk of downside correction has grown — I would advise investors to stay defensive here."
Viktoras Karapetjanc, expert at Traders Union, believes the long-term bullish structure remains intact for Reckitt Benckiser. He views the strong sales momentum and expanded buyback as clear signals of management’s confidence and capital discipline. Karapetjanc highlights the resilience above key moving averages and anticipates further upside should the price exceed GBX5,392. "With continued capital returns and robust core growth, I see further opportunity for price appreciation in the coming sessions."
Jainam Mehta, market strategist, notes Reckitt Benckiser trades with mixed technical signals. He observes bullish momentum but cautions that stretched RSI and intraday weakness suggest a ripe setup for a tactical fade. Mehta points out the potential for a breakout above GBX5,392, but sees value in waiting for clear confirmation. "If selling abates and a short-term pullback holds above GBX5,310, I’d watch for a contrarian entry on momentum reversal."
Reckitt Benckiser asset chart
Reckitt Benckiser price dynamics. Source: TradingView.

Bullish bias holds as overbought momentum meets volatile retreat

Reckitt Benckiser is trading above both the 20-day (GBX5,064) and 50-day (GBX4,825) moving averages, confirming a bullish short- and medium-term trend, but remains beneath the 200-day moving average at GBX5,579. Today’s price has tested a near-term support at GBX5,310 and resistance at GBX5,392, with the Ichimoku Kijun at GBX4,751 providing deeper baseline support. Momentum indicators such as MACD and ADX stay bullish, while overbought signals are evident in an RSI of 69.72, CCI of 311.19, Bull/Bear Power at 479.64, and Stochastic RSI at 100. Intraday action is dominated by buyers, yet the stock has retreated toward session lows amid high volatility and a negative daily swing. The Awesome Oscillator continues to confirm the bullish bias, but intraday pressure signals increased short-term profit-taking.

Earlier, analysts noted that Reckitt Benckiser’s robust operational results and capital returns had bolstered optimism for the stock’s near-term outlook. The current technical setup, reinforced by resilient demand signals and ongoing buybacks, now puts focus on a sustained move above GBX5,392 as the key trigger for renewed upside momentum.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.